New this week from DTR!
TRENDING STORIES THIS WEEK IN THE DRUG INDUSTRY:
In this Q&A, Keith Murphy, CEO of Organovo, discusses how the shift from animal models to 3D human tissues can transform the preclinical space. Read more here >>>
In this interview, Dr Bruce Leuchter explores the hurdles faced by the sector of neuroscience, and discusses the historical dynamics that have influenced investor interest. Download now .
Read more on our Q&A session with Dr Jia-Jia Zhang, we discuss the novel mechanism and the promising translational value of 3A5C7 mAb in the treatment of morphine tolerance.
Download now to discover more on a learning-based framework that enables patients and caregivers to predict the timing of any of the five clinical groups of AD development.
The interactions linking intestinal microbiota with the functionality of basally resident alveolar macrophages and severity of infection are revealed by Scientists at the Center for Translational Antiviral Research in the Institute for Biomedical Sciences at Georgia State University. Read more here.
WHAT TO WATCH:
Join this webinar to delve into the challenges that researchers come across when using certain viral vectors in gene therapy, and how this has helped them develop a new generation of precise vectors with sustainable effects.
Discover more about functional cell-based assays for characterizing novel therapeutics & biosimilars targeting cytokines in inflammation & oncology. Click here to register your space.
领英推荐
TRENDING THIS WEEK :
Discover the way to do flow cytometry in an easier way with Sartorius iQue's handbook. Learn how to bring speed, throughput, multiplexing and miniaturization to your bench. Download your guide here >>>
Read more about Euretos computational disease model and how it predicts many of the known drug targets for RA. You will also learn:
Our inaugural report, which is written carefully and in huge detail by our editorial team, has delved into the topic of stem cells. This includes the remarkable advancements and the field of drug discovery within the stem call sector.
If you would like to find out more, click here .
WHAT TO LISTEN TO:
Have you managed to give our first podcast of 2024 a listen yet? It's the ideal listen for your journey to work, to broaden your knowledge on research insights and projections for the field in 2024 in neuroscience.
WHAT TO READ:
This article discusses how researchers have identified two unique proteins within N. fowleri – self-activating guanine nucleotide-hydrolysing proteins (G proteins) – that present novel targets for drug discovery. Read on here >>>
SIGN UP FOR FREE TO STAY IN THE KNOW:
Sign up here to stay ahead of all the latest breaking news, expert insights and the newest trends in global drug discovery.
Drug Target Review is an essential multimedia resource which is trusted and recognised globally of researchers and scientific leaders who cover the most up-to-date innovations, and cutting edge technologies in the industry.